Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Category
Global or ExUS Equities - Industry Sector
Sponsor
Franklin Templeton
Fund Family
Index
-
Index Weighting
Active/Passive
Expense
0.50%
Inverse/Leveraged
IPO
Feb 27, 2020
Asset Type
Equities (Stocks)
ETF Type
Bond Type
Average Maturity
Commodity Type
Quant Type
ESG Type
Dividend Type
Structure Type
Growth/Value
Market Cap
Option/Short
Yes / Yes
Tags
Tags
Tags
Tags
Tags
-
Tags
-
Tags
-
Sector/Theme
Region
SMA20
-6.58%
SMA50
-6.32%
SMA200
5.81%
Return% 1Y
16.49%
Return% 3Y
14.68%
Return% 5Y
-3.86%
Return% 10Y
Return% SI
Flows% 1M
0.00%
Flows% 3M
6.60%
Flows% YTD
31.81%
Flows% 1Y
Flows% 3Y
Flows% 5Y
Trades
Total Holdings
70
AUM
33.03M
NAV/sh
52W High
46.22 -12.78%
52W Low
31.24 29.03%
Volatility
0.91% 1.10%
ATR (14)
0.87
RSI (14)
37.72
Beta
0.99
Rel Volume
0.31
Avg Volume
5.84K
Volume
947
Perf Week
-5.18%
Perf Month
-5.58%
Perf Quarter
-4.79%
Perf Half Y
17.86%
Perf YTD
11.03%
Perf Year
13.25%
Perf 3Y
46.25%
Perf 5Y
-20.51%
Perf 10Y
-
Prev Close
40.83
Price
40.31
Change %
-1.26%
Franklin Genomic Advancements ETF seeks capital appreciation. Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements. The fund invests predominantly in common stock. Although it may invest across economic sectors, the fund concentrates its investments in health care related industries. It is non-diversified.